Indication

Chronic Staphylococcus epidermidis prostatitis

Chronic *Staphylococcus epidermidis* prostatitis is a persistent or recurrent bacterial infection and inflammation of the prostate gland in adult males, specifically attributed to the coagulase-negative bacterium *Staphylococcus epidermidis*. Read more about Chronic Staphylococcus epidermidis prostatitis

50 drugs 46 manufacturers

Advertisement

Drugs that treat it

Common Chronic Staphylococcus epidermidis prostatitis therapies.

Showing 19–27 of 50 drugs

Filter & compare in the drug finder →Opens the drug finder with Chronic Staphylococcus epidermidis prostatitis preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Chronic Staphylococcus epidermidis prostatitis.

Chronic *Staphylococcus epidermidis* prostatitis is a persistent or recurrent bacterial infection and inflammation of the prostate gland in adult males, specifically attributed to the coagulase-negative bacterium *Staphylococcus epidermidis*.

While traditionally regarded as a commensal of the skin and anterior urethra, the organism can act as an opportunistic uropathogen within the male genitourinary tract, often forming recalcitrant biofilms within prostatic tissue or calcifications.

Pathophysiologically, localized microcolonies within the gland lead to chronic inflammation, presenting clinically with protracted pelvic, perineal, or lower back pain, dysuria, urinary frequency, and recurrent lower urinary tract infections.

Diagnosis relies on isolating high colony counts of the organism from expressed prostatic secretions or post-prostatic massage urine specimens, distinguishing true infection from superficial urethral contamination.

Personalize your experience

Follow Chronic Staphylococcus epidermidis prostatitis and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it